ArticleCureus2026
A Case of Hemolysis, Elevated Liver Enzyme, and Low Platelet Count (HELLP) Syndrome-Precipitated Acute Thrombotic Thrombocytopenia Purpura.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemolysis, elevated liver enzyme, and low platelet count (HELLP) syndrome and thrombotic thrombocytopenic purpura (TTP) are both thrombotic microangiopathies that share overlapping clinical and laboratory features, making differentiation during pregnancy particularly challenging. We present a case of a 27-year-old woman at 21 weeks gestation who initially presented with hypertensive emergency and right middle cerebral artery (MCA) ischemic stroke requiring embolectomy and whose subsequent intensive care unit (ICU) course was complicated by fever, severe thrombocytopenia, microangiopathic hemolytic anemia (MAHA), and transaminitis raising concern for concurrent HELLP syndrome and TTP. Further workup revealed undetectably low ADAMTS-13 activity with negative inhibitor and identification of two heterozygous pathogenic ADAMTS-13 gene variants, confirming a diagnosis of hereditary TTP superimposed on HELLP syndrome. Management was complicated by the need for platelet transfusion prior to delivery despite its contraindication in TTP, which required multidisciplinary collaboration between Ob/Gyn perinatology and hematology. The decision was made to manage concurrent HELLP and TTP with emergent delivery followed by plasma exchange (PLEX). This unique case demonstrates the challenges of diagnosing and starting appropriate management when there is concern for both HELLP and TTP due to the significant clinical and laboratory overlap. Additionally, a high index of suspicion should be maintained for the possibility of pregnancy precipitating acute-on-chronic hereditary TTP events in patients presenting with severe thrombocytopenia and prior unexplained pregnancy loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.